An acute remission of Reiter's syndrome in male patients treated with bromocriptine.
We describe 4 male patients with Reiter's syndrome treated with bromocriptine. All 4 had infectious gastroenteritis and chronic Reiter's syndrome with arthritis and enthesopathy that persisted despite treatment in 3 with antiinflammatory drugs and 1 with sulfasalazine for long periods. In all patients treatment was cancelled 8 days before bromocriptine treatment. In 2 patients a dramatic improvement was observed 24 h after 2.5 mg/day of bromocriptine. Two patients improved after 4 days of bromocriptine treatment (5 mg/day). All 4 patients remained asymptomatic for at least 4 months of bromocriptine treatment. Bromocriptine may be useful for treating male patients with Reiter's syndrome.
Bravo
G
G
Rheumatic Diseases Unit, Hospital de Especialidades, Centro Medico La Raza, IMSS, Mexico City.
Zazueta
B
B
Lavalle
C
C
D000328:Adult; D016918:Arthritis, Reactive / Q000150:complications / Q000188:drug therapy*; D001971:Bromocriptine / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005759:Gastroenteritis / Q000150:complications / Q000188:drug therapy; D006801:Humans; D008297:Male; D012074:Remission Induction; D012460:Sulfasalazine / Q000627:therapeutic use
D001971:Bromocriptine; D012460:Sulfasalazine